(Boursier.com) — The group Bastide announces that it has been designated by the NHS (National Health Service) as the exclusive operator in Respiratory Assistance (oxygen therapy) in the East of England region, in the United Kingdom. This new contract, lasting 7 years, extendable to 10 years, will bring additional turnover of around 10 ME per year.
Bastide will begin operating in this region before the end of 2024, once the administrative and legal phase is finalized. With this new contract, the British subsidiary Baywater Healthcare is now the exclusive operator in 5 of the 11 British regions (East of England, North West, West Midlands, Wales, Yorkshire). The group is consolidating its position as the leading local player, with more than 37,000 patients now receiving oxygen therapy and an annual turnover of around €50 million over a full year.
Bastide adds that this coverage could further expand with the London region, the allocation of which is expected soon, and for which Bastide had been designated, before the recourse of the operator currently in place.
©2024 Boursier.com